NEOS Neos Therapeutics Inc.

2.49
+0.09  (+4%)
Previous Close 2.4
Open 2.47
Price To Book -4.61
Market Cap 123693994
Shares 49,676,303
Volume 122,638
Short Ratio
Av. Daily Volume 415,314

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced September 15, 2017.
NT-0201
Attention deficit hyperactivity disorder (ADHD)
Approved January 27, 2016.
Adzenys XR-ODT
Attention deficit hyperactivity disorder (ADHD)
Approval announced June 19, 2017.
Cotempla XR-ODT
Attention deficit hyperactivity disorder (ADHD)